NM_173728.4:c.2337C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_173728.4(ARHGEF15):c.2337C>T(p.Ser779Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000959 in 1,607,888 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00091 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00096 ( 27 hom. )
Consequence
ARHGEF15
NM_173728.4 synonymous
NM_173728.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.29
Publications
1 publications found
Genes affected
ARHGEF15 (HGNC:15590): (Rho guanine nucleotide exchange factor 15) Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein-coupled receptors. This gene encodes a protein that functions as a specific guanine nucleotide exchange factor for RhoA. It also interacts with ephrin A4 in vascular smooth muscle cells. Two alternatively spliced transcripts variants that encode the same protein have been found for this gene. [provided by RefSeq, Aug 2010]
ARHGEF15 Gene-Disease associations (from GenCC):
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- schizophreniaInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 17-8319566-C-T is Benign according to our data. Variant chr17-8319566-C-T is described in ClinVar as Benign. ClinVar VariationId is 461432.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.29 with no splicing effect.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000906 (138/152324) while in subpopulation EAS AF = 0.0218 (113/5178). AF 95% confidence interval is 0.0186. There are 1 homozygotes in GnomAd4. There are 69 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 138 Unknown,AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ARHGEF15 | NM_173728.4 | c.2337C>T | p.Ser779Ser | synonymous_variant | Exon 15 of 16 | ENST00000361926.8 | NP_776089.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ARHGEF15 | ENST00000361926.8 | c.2337C>T | p.Ser779Ser | synonymous_variant | Exon 15 of 16 | 1 | NM_173728.4 | ENSP00000355026.3 | ||
| ARHGEF15 | ENST00000421050.2 | c.2337C>T | p.Ser779Ser | synonymous_variant | Exon 15 of 16 | 1 | ENSP00000412505.1 | |||
| ARHGEF15 | ENST00000647883.1 | c.1800C>T | p.Ser600Ser | synonymous_variant | Exon 12 of 13 | ENSP00000498197.1 | ||||
| ENSG00000226871 | ENST00000820533.1 | n.100-787G>A | intron_variant | Intron 1 of 3 |
Frequencies
GnomAD3 genomes AF: 0.000913 AC: 139AN: 152206Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
139
AN:
152206
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00127 AC: 310AN: 244100 AF XY: 0.00104 show subpopulations
GnomAD2 exomes
AF:
AC:
310
AN:
244100
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000965 AC: 1404AN: 1455564Hom.: 27 Cov.: 31 AF XY: 0.000893 AC XY: 647AN XY: 724202 show subpopulations
GnomAD4 exome
AF:
AC:
1404
AN:
1455564
Hom.:
Cov.:
31
AF XY:
AC XY:
647
AN XY:
724202
show subpopulations
African (AFR)
AF:
AC:
2
AN:
32946
American (AMR)
AF:
AC:
15
AN:
42778
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25798
East Asian (EAS)
AF:
AC:
1339
AN:
39552
South Asian (SAS)
AF:
AC:
4
AN:
85222
European-Finnish (FIN)
AF:
AC:
0
AN:
53318
Middle Eastern (MID)
AF:
AC:
0
AN:
5700
European-Non Finnish (NFE)
AF:
AC:
4
AN:
1110186
Other (OTH)
AF:
AC:
40
AN:
60064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
83
166
249
332
415
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000906 AC: 138AN: 152324Hom.: 1 Cov.: 32 AF XY: 0.000926 AC XY: 69AN XY: 74482 show subpopulations
GnomAD4 genome
AF:
AC:
138
AN:
152324
Hom.:
Cov.:
32
AF XY:
AC XY:
69
AN XY:
74482
show subpopulations
African (AFR)
AF:
AC:
6
AN:
41576
American (AMR)
AF:
AC:
14
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
113
AN:
5178
South Asian (SAS)
AF:
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4
AN:
68032
Other (OTH)
AF:
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
8
15
23
30
38
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
20
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Developmental and epileptic encephalopathy Benign:1
Jan 19, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.